Newsroom

Newsroom

NeoGenomics Reports Third Quarter 2023 Results

Press Release
Read More

Molecular profiling of patients with colorectal cancer and their clinical implications

Literature
Read More

Spatial characterization of pro-inflammatory pathways in the pathogenesis of IBD associated colorectal cancer

Literature
Read More

High-throughput analysis of immune biomarkers from brightfield whole tumor images using IndicaHALO®

Literature
Read More

Optimization of an Integrated MultiOmyx-RNAscopehyperplexassay for co-detection and characterization of multiple protein and RNA biomarkers within the tumor microenvironment (TME)

Literature
Read More

NeoGenomics highlighting advances in drug development strategies at recent clinical meetings

Blog
Read More

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios

Press Release
Read More

Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients